GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Denis Chem Lab Ltd (BOM:537536) » Definitions » Debt-to-EBITDA

Denis Chem Lab (BOM:537536) Debt-to-EBITDA : 0.00 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Denis Chem Lab Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Denis Chem Lab's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Denis Chem Lab's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Denis Chem Lab's annualized EBITDA for the quarter that ended in Dec. 2023 was ₹250 Mil. Denis Chem Lab's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Denis Chem Lab's Debt-to-EBITDA or its related term are showing as below:

BOM:537536' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.08   Med: 1.78   Max: 5.37
Current: 0.08

During the past 11 years, the highest Debt-to-EBITDA Ratio of Denis Chem Lab was 5.37. The lowest was 0.08. And the median was 1.78.

BOM:537536's Debt-to-EBITDA is ranked better than
89.19% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs BOM:537536: 0.08

Denis Chem Lab Debt-to-EBITDA Historical Data

The historical data trend for Denis Chem Lab's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denis Chem Lab Debt-to-EBITDA Chart

Denis Chem Lab Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 0.91 0.84 0.21 0.10

Denis Chem Lab Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.10 - 0.07 -

Competitive Comparison of Denis Chem Lab's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Denis Chem Lab's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Denis Chem Lab's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Denis Chem Lab's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Denis Chem Lab's Debt-to-EBITDA falls into.



Denis Chem Lab Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Denis Chem Lab's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(10.129 + 9.207) / 190.332
=0.10

Denis Chem Lab's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Denis Chem Lab  (BOM:537536) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Denis Chem Lab Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Denis Chem Lab's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Denis Chem Lab (BOM:537536) Business Description

Traded in Other Exchanges
N/A
Address
Satellite Road, 401 Abhishree Complex, Opposite OM Tower, Beside Bidiwala Park, Ahmedabad, GJ, IND, 380015
Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.

Denis Chem Lab (BOM:537536) Headlines

No Headlines